- Home
- KALA vs SWIN Comparison
KALA vs SWIN Comparison
Compare KALA & SWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- SWIN
- Stock Information
- Founded
- KALA 2009
- SWIN 2017
- Country
- KALA United States
- SWIN Hong Kong
- Employees
- KALA N/A
- SWIN N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- SWIN
- Sector
- KALA Health Care
- SWIN
- Exchange
- KALA Nasdaq
- SWIN Nasdaq
- Market Cap
- KALA 27.3M
- SWIN 24.9M
- IPO Year
- KALA 2017
- SWIN 2023
- Fundamental
- Price
- KALA $6.64
- SWIN $1.29
- Analyst Decision
- KALA Strong Buy
- SWIN
- Analyst Count
- KALA 2
- SWIN 0
- Target Price
- KALA $15.00
- SWIN N/A
- AVG Volume (30 Days)
- KALA 108.1K
- SWIN 85.6K
- Earning Date
- KALA 03-28-2025
- SWIN 03-04-2025
- Dividend Yield
- KALA N/A
- SWIN N/A
- EPS Growth
- KALA N/A
- SWIN N/A
- EPS
- KALA N/A
- SWIN N/A
- Revenue
- KALA N/A
- SWIN $2,419,000.00
- Revenue This Year
- KALA N/A
- SWIN N/A
- Revenue Next Year
- KALA N/A
- SWIN $61.68
- P/E Ratio
- KALA N/A
- SWIN N/A
- Revenue Growth
- KALA N/A
- SWIN N/A
- 52 Week Low
- KALA $4.21
- SWIN $1.16
- 52 Week High
- KALA $11.20
- SWIN $72.55
- Technical
- Relative Strength Index (RSI)
- KALA 39.29
- SWIN 37.31
- Support Level
- KALA $6.50
- SWIN $1.16
- Resistance Level
- KALA $8.65
- SWIN $1.56
- Average True Range (ATR)
- KALA 0.90
- SWIN 0.14
- MACD
- KALA -0.43
- SWIN -0.01
- Stochastic Oscillator
- KALA 2.98
- SWIN 28.26
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.